1. Migraine: developing drugs for acute treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, February 2018 Subject(s): Clinical Trials as TopicDrug Evaluation -- standardsMigraine Disorders -- drug therapyAcute DiseaseAdultChildResearch DesignHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 3, 2018 Subject(s): Calcitonin Gene-Related Peptide Receptor Antagonists -- therapeutic useMigraine Disorders -- drug therapyMigraine Disorders -- prevention & controlCalcitonin Gene-Related Peptide Receptor Antagonists -- adverse effectsChronic DiseaseClinical Trials as TopicTreatment OutcomeHumansUnited States
